Chinook Therapeutics, Inc. Profile Avatar - Palmy Investing

Chinook Therapeutics, Inc.

Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin recepto…

Biotechnology
US, Seattle [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Chinook Therapeutics, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Chinook Therapeutics, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Chinook Therapeutics, Inc..

End of KDNY's Analysis
CIK: 1435049 CUSIP: 16961L106 ISIN: US00739L1017 LEI: - UEI: -
Secondary Listings
KDNY has no secondary listings inside our databases.